- Home
- DYN vs EVTC Comparison
DYN vs EVTC Comparison
Compare DYN & EVTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- EVTC
- Stock Information
- Founded
- DYN 1984
- EVTC 1988
- Country
- DYN United States
- EVTC United States
- Employees
- DYN N/A
- EVTC N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- EVTC EDP Services
- Sector
- DYN Health Care
- EVTC Technology
- Exchange
- DYN Nasdaq
- EVTC Nasdaq
- Market Cap
- DYN 1.9B
- EVTC 2.1B
- IPO Year
- DYN 2020
- EVTC 2013
- Fundamental
- Price
- DYN $14.22
- EVTC $34.49
- Analyst Decision
- DYN Strong Buy
- EVTC Hold
- Analyst Count
- DYN 14
- EVTC 5
- Target Price
- DYN $34.93
- EVTC $39.00
- AVG Volume (30 Days)
- DYN 2.4M
- EVTC 294.8K
- Earning Date
- DYN 07-28-2025
- EVTC 07-30-2025
- Dividend Yield
- DYN N/A
- EVTC 0.58%
- EPS Growth
- DYN N/A
- EVTC 102.95
- EPS
- DYN N/A
- EVTC 2.13
- Revenue
- DYN N/A
- EVTC $886,589,000.00
- Revenue This Year
- DYN N/A
- EVTC $9.23
- Revenue Next Year
- DYN N/A
- EVTC $4.84
- P/E Ratio
- DYN N/A
- EVTC $16.11
- Revenue Growth
- DYN N/A
- EVTC 12.93
- 52 Week Low
- DYN $6.36
- EVTC $31.11
- 52 Week High
- DYN $37.08
- EVTC $38.56
- Technical
- Relative Strength Index (RSI)
- DYN 73.48
- EVTC 41.52
- Support Level
- DYN $13.03
- EVTC $34.08
- Resistance Level
- DYN $13.85
- EVTC $36.52
- Average True Range (ATR)
- DYN 0.64
- EVTC 0.66
- MACD
- DYN 0.04
- EVTC -0.28
- Stochastic Oscillator
- DYN 95.55
- EVTC 12.42
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About EVTC Evertec Inc.
Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions which derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. It derives maximum revenue from Latin America Payments and Solutions. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.